Cargando…

Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme

PURPOSE: HOXD10 is a tumor modulator that can either be a tumor-suppressor or a tumor-promoting gene. However, the role of HOXD10 in glioblastoma multiforme (GBM) remains unclear. METHODS: Immunohistochemistry (IHC) was applied to detect protein expression of HOXD10 in GBM and normal brain tissue pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yanxin, Ma, Ke, Xie, Qi, Zhang, Xianwei, Zhang, Xiulei, Chen, Kui, Kong, Lingfei, Qian, Rongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558040/ https://www.ncbi.nlm.nih.gov/pubmed/34737577 http://dx.doi.org/10.2147/OTT.S336225

Ejemplares similares

High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma
por: Ma, Ke, et al.
Publicado: (2023)

Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
por: Ye, Yintao, et al.
Publicado: (2023)

Hoxd10 Is Required Systemically for Secretory Activation in Lactation and Interacts Genetically with Hoxd9
por: Landua, John D., et al.
Publicado: (2020)

High metallothionein predicts poor survival in glioblastoma multiforme
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme
por: Cheray, Mathilde, et al.
Publicado: (2020)

Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis()
por: Zhu, Junle, et al.
Publicado: (2017)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses
por: Anton, Jellyca, et al.
Publicado: (2021)

Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
por: Hou, Aiwu, et al.
Publicado: (2016)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis
por: Higa, Nayuta, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

SAMSN1 Is Highly Expressed and Associated with a Poor Survival in Glioblastoma Multiforme
por: Yan, Yong, et al.
Publicado: (2013)

Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme
por: Kasl, Rebecca A., et al.
Publicado: (2016)

miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition
por: Yachi, Kazuhiro, et al.
Publicado: (2018)

HOXD‐AS2‐STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma
por: Zhang, Zuo‐Xin, et al.
Publicado: (2023)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer
por: Li, Xiang, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
por: Dong, Jiawei, et al.
Publicado: (2022)

A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma
por: Wang, Lumin, et al.
Publicado: (2023)

Increased RLIP76 expression in IDH1 wild-type glioblastoma multiforme is associated with worse prognosis
por: Wang, Qi, et al.
Publicado: (2020)

Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme
por: Lopes-Ramos, Camila M., et al.
Publicado: (2021)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017)

Human Endogenous Retroviruses in Glioblastoma Multiforme
por: Yuan, Zihao, et al.
Publicado: (2021)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer
por: Sun, Xiaomei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j1datfhqm0t15mthvenbi2n6ko